SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 26, 2026

IMVT

Immunovant, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago
Insider cluster: 5 insiders, $2.4M total
Actionable Insight • Neutral

The insider selling cluster is too small relative to market cap to be informative. Monitor for upcoming clinical data catalysts (e.g., batoclimab or IMVT-1402 readouts) that could drive the stock, as the insider activity itself provides no actionable signal.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
IMVT ▼ -3.17% at T+60d
NEUTRAL call -3.17% · α vs SPY -7.55% · entry $38.51 → $37.29
Entry = T+0 close
Jun 26, 2026
via day close
T+1d
+0.05%
call +0.05% · α -0.73%
$38.53
settled 4mo ago
T+5d
+0.23%
call +0.23% · α -1.15%
$38.60
settled 4mo ago
T+20d
+2.34%
call +2.34% · α +2.62%
$39.41
settled 3mo ago
T+60d
-3.17%
call -3.17% · α -7.55%
$37.29
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Five Immunovant insiders (CFO, CTO, CLO, COO, and a director) collectively sold ~$2.4M in open-market shares on June 26, 2026. CEO Eric Venker also exercised options and disposed shares to the issuer on July 1, followed by a small open-market sale on July 2. The total open-market sales of ~$2.52M represent just 0.03% of Immunovant's $8B market cap, making the cluster economically trivial and unlikely to signal material negative information.

Key Financial Metrics

Direction
selling
Total Value
$2.4M
Insiders
5

Key Facts

  • Five insiders sold shares on June 26, 2026: CFO Tiago Girao ($385K), CTO Jay Stout ($1.27M), CLO Christopher Van Tuyl ($572K), COO Melanie Gloria ($116K), and Director Atul Pande ($57K).
  • CEO Eric Venker exercised 92,188 options at $14.46 on July 1, then disposed 86,629 shares to the issuer at $38.14 (likely for tax withholding), and sold 3,092 shares open-market at $38.48 on July 2.
  • Total open-market sales from the cluster and CEO amount to ~$2.52M, or 0.03% of the $8.0B market cap.
  • All sales occurred near $38 per share, with no unusual clustering beyond the single day for the five insiders.

Financial Impact

Total open-market sales of ~$2.52M represent 0.03% of Immunovant's $8B market cap — immaterial. CEO's derivative exercise and disposition to issuer are non-cash or tax-related events with no net economic impact on the market.

dilutioninsider ownership

Risk Factors

  • Insider selling could increase if the stock appreciates further, but current levels are routine.
  • No specific negative catalyst is indicated by this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (24 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMVT-1783371724046
12 reports for IMVT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IMVT — sortable, filterable
TypeNow
Aug 6, 2026
11w ago
8-K
BEARISH ★ 6/10
$39.74 $39.12▲ +1.56%▲ +2.16%$27.68 (+30.35%)
Jul 24, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.09 $43.32▲ +8.06%▲ +4.76%$27.68 (−30.96%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 4/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 15, 2026
18w ago
144
NEUTRAL ★ 2/10
$33.61 $38.77▲ +15.35%▲ +15.15%$27.68 (−17.64%)
May 28, 2026
21w ago
144
NEUTRAL ★ 3/10
$33.30 $38.51▲ +15.65%▲ +17.44%$27.68 (−16.88%)
May 20, 2026
22w ago
8-K
MIXED ★ 6/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
May 20, 2026
22w ago
Press Release
BULLISH ★ 7/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
Showing 10 of 12

US Market Status

Market Open — Closes in 5h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 6, 2026